Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.

PRE-VIEW: Development and Pilot Testing of An Interactive Video Doctor Plus Provider Alert to Increase Cancer Screening.

Arora M, Gerbert B, Potter MB, Gildengorin G, Walsh JM.

ISRN Prev Med. 2013;2013. doi: 10.5402/2013/935487.

2.

Informed consent for clinical treatment.

Hall DE, Prochazka AV, Fink AS.

CMAJ. 2012 Mar 20;184(5):533-40. doi: 10.1503/cmaj.112120. Epub 2012 Mar 5. Review. No abstract available.

3.

Applying strategies from libertarian paternalism to decision making for prostate specific antigen (PSA) screening.

Wheeler DC, Szymanski KM, Black A, Nelson DE.

BMC Cancer. 2011 Apr 21;11:148. doi: 10.1186/1471-2407-11-148.

4.
5.

Applicability of a video intervention to increase informed decision making for prostate-specific antigen testing.

Ross L, Ashford AD, Bleechington SJ, Dark T, Erwin DO.

J Natl Med Assoc. 2010 Mar;102(3):228-36.

6.

A structured implicit abstraction method to evaluate whether content of counseling before prostate cancer screening is consistent with recommendations by experts.

Farrell MH, Chan EC, Ladouceur LK, Stein JM.

Patient Educ Couns. 2009 Dec;77(3):322-7. doi: 10.1016/j.pec.2009.09.023. Epub 2009 Oct 17.

8.

Lack of comprehension of common prostate cancer terms in an underserved population.

Kilbridge KL, Fraser G, Krahn M, Nelson EM, Conaway M, Bashore R, Wolf A, Barry MJ, Gong DA, Nease RF Jr, Connors AF.

J Clin Oncol. 2009 Apr 20;27(12):2015-21. doi: 10.1200/JCO.2008.17.3468. Epub 2009 Mar 23.

9.

A randomized trial comparing web-based decision aids on prostate cancer knowledge for African-American men.

Ellison GL, Weinrich SP, Lou M, Xu H, Powell IJ, Baquet CR.

J Natl Med Assoc. 2008 Oct;100(10):1139-45.

10.

Low-literacy interventions to promote discussion of prostate cancer: a randomized controlled trial.

Kripalani S, Sharma J, Justice E, Justice J, Spiker C, Laufman LE, Price M, Weinberg AD, Jacobson TA.

Am J Prev Med. 2007 Aug;33(2):83-90. Erratum in: Am J Prev Med. 2008 Mar;34(3):270. Jacobson, Terry A [added].

11.

Moving towards shared decision making in prostate cancer screening.

Hoffman RM, Helitzer DL.

J Gen Intern Med. 2007 Jul;22(7):1056-7. No abstract available.

12.

A systematic review of information in decision aids.

Feldman-Stewart D, Brennenstuhl S, McIssac K, Austoker J, Charvet A, Hewitson P, Sepucha KR, Whelan T.

Health Expect. 2007 Mar;10(1):46-61. Review.

13.

Women's accounts of consenting to surgery: is consent a quality problem?

Habiba M, Jackson C, Akkad A, Kenyon S, Dixon-Woods M.

Qual Saf Health Care. 2004 Dec;13(6):422-7.

14.
15.

Agreement between prostate cancer patients and their clinicians about utilities and attribute importance.

Elstein AS, Chapman GB, Chmiel JS, Knight SJ, Chan C, Nadler RB, Kuzel TM, Siston AK, Bennett CL.

Health Expect. 2004 Jun;7(2):115-25.

16.

Current status of PSA screening. Early detection of prostate cancer.

Pickles T.

Can Fam Physician. 2004 Jan;50:57-63. Review.

17.

African American men, prostate cancer screening and informed decision making.

Sellers DB, Ross LE.

J Natl Med Assoc. 2003 Jul;95(7):618-25.

18.

Physician perspectives on the importance of facts men ought to know about prostate-specific antigen testing.

Chan EC, Vernon SW, Haynes MC, O'Donnell FT, Ahn C.

J Gen Intern Med. 2003 May;18(5):350-6.

19.

Informed consent for cancer screening with prostate-specific antigen: how well are men getting the message?

Chan EC, Vernon SW, O'Donnell FT, Ahn C, Greisinger A, Aga DW.

Am J Public Health. 2003 May;93(5):779-85.

20.

Beliefs and expectations of women under 50 years old regarding screening mammography: a qualitative study.

Nekhlyudov L, Ross-Degnan D, Fletcher SW.

J Gen Intern Med. 2003 Mar;18(3):182-9.

Supplemental Content

Support Center